(NASDAQ:SNTI), NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Senti Biosciences, Inc. (“Senti” or the “Company”) (NASDAQ: SNTI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Senti and certain of its officers and/or directors have […]

(NASDAQ:JACK), NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Jack in the Box Inc. (“Jack in the Box” or the “Company”) (NASDAQ: JACK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Jack in the Box

(NASDAQ:TMUS), NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of T-Mobile US, Inc. (“T-Mobile” or the “Company”) (NASDAQ: TMUS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether T-Mobile and certain of its officers and/or directors have

(NYSE:FCN), NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of FTI Consulting, Inc. (“FTI” or the “Company”) (NYSE: FCN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether FTI and certain of its officers and/or directors have

(NYSE:AMTB), NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Amerant Bancorp Inc. (“Amerant” or the “Company”) (NYSE: AMTB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Amerant and certain of its officers and/or directors have

(NYSE:WNC), NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Wabash National Corporation (“Wabash” or the “Company”) (NYSE: WNC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Wabash and certain of its officers and/or directors have

(NYSE:BLCO), NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation (“Bausch + Lomb” or the “Company”) (NYSE: BLCO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Bausch + Lomb and certain of

(NASDAQ:GOCO), NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of GoHealth, Inc. (“GoHealth” or the “Company”) (NASDAQ: GOCO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether GoHealth and certain of its officers and/or directors have engaged

(NYSE:SLQT), NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether SelectQuote and certain of its officers and/or directors have engaged

(NASDAQ:ARVN), NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Arvinas, Inc. (“Arvinas” or the “Company”) (NASDAQ: ARVN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Arvinas and certain of its officers and/or directors have engaged